@article{article, title  = {{Patient-Reported Outcomes (PROs) With Abrocitinib Treatment in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN Study}},

 url = {{}},

 year = {{2021}},

 month = {{2}},

 author = {{McMichael A and Cork M and Teng J and Rojo R and Valdez H and Zhang F and Myers D and Chan G and DiBonaventura M}},

 doi = {{10.1016/j.jaci.2020.12.560}},

 volume = {{147}},

 journal = {{Journal of Allergy and Clinical Immunology}},

 issue = {{2}},

 pages = {{ab156}},

 note = {{Accessed on 2024/12/22}}}